 James Finigan
Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acute Lung Injury | 5 | 2012 | 301 | 1.280 |
Why?
| | Neuregulin-1 | 5 | 2019 | 49 | 1.040 |
Why?
| | Protein C | 4 | 2012 | 53 | 0.920 |
Why?
| | Respiratory Mucosa | 5 | 2018 | 322 | 0.900 |
Why?
| | Blood Coagulation Factors | 2 | 2012 | 60 | 0.570 |
Why?
| | Receptors, Cell Surface | 3 | 2012 | 370 | 0.560 |
Why?
| | Lung | 8 | 2019 | 4089 | 0.540 |
Why?
| | Cell Membrane Permeability | 1 | 2016 | 87 | 0.470 |
Why?
| | ErbB Receptors | 3 | 2016 | 632 | 0.460 |
Why?
| | Signal Transduction | 7 | 2019 | 5185 | 0.460 |
Why?
| | Lung Neoplasms | 5 | 2020 | 2660 | 0.430 |
Why?
| | Adherens Junctions | 1 | 2014 | 24 | 0.430 |
Why?
| | Epithelial Cells | 2 | 2018 | 1106 | 0.400 |
Why?
| | Cell Adhesion | 1 | 2014 | 452 | 0.380 |
Why?
| | beta Catenin | 1 | 2014 | 252 | 0.360 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2012 | 630 | 0.360 |
Why?
| | Capillary Permeability | 3 | 2010 | 132 | 0.360 |
Why?
| | Respiration, Artificial | 3 | 2012 | 710 | 0.300 |
Why?
| | Permeability | 4 | 2015 | 169 | 0.300 |
Why?
| | Extravascular Lung Water | 1 | 2009 | 9 | 0.300 |
Why?
| | Smoking | 1 | 2016 | 1467 | 0.290 |
Why?
| | Electric Impedance | 3 | 2016 | 110 | 0.270 |
Why?
| | Early Detection of Cancer | 1 | 2013 | 472 | 0.270 |
Why?
| | Transcriptional Activation | 2 | 2011 | 372 | 0.260 |
Why?
| | Glycoproteins | 1 | 2009 | 353 | 0.250 |
Why?
| | Epithelium | 3 | 2019 | 310 | 0.240 |
Why?
| | Blood Coagulation | 1 | 2008 | 268 | 0.240 |
Why?
| | Receptors, Lysosphingolipid | 1 | 2005 | 13 | 0.220 |
Why?
| | Adenocarcinoma | 1 | 2012 | 923 | 0.220 |
Why?
| | Endothelium | 1 | 2005 | 119 | 0.210 |
Why?
| | Endothelium, Vascular | 2 | 2008 | 949 | 0.210 |
Why?
| | Cell Line | 3 | 2016 | 2821 | 0.210 |
Why?
| | Interleukin-6 | 3 | 2019 | 770 | 0.210 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2754 | 0.190 |
Why?
| | ADAM17 Protein | 2 | 2012 | 42 | 0.170 |
Why?
| | ADAM Proteins | 2 | 2012 | 64 | 0.170 |
Why?
| | Phosphorylation | 4 | 2019 | 1704 | 0.160 |
Why?
| | Hydroxychloroquine | 1 | 2020 | 63 | 0.160 |
Why?
| | Pulmonary Medicine | 1 | 2020 | 78 | 0.150 |
Why?
| | RNA, Small Interfering | 3 | 2014 | 631 | 0.150 |
Why?
| | Small Cell Lung Carcinoma | 1 | 2020 | 121 | 0.140 |
Why?
| | Chemokine CCL11 | 1 | 2018 | 25 | 0.140 |
Why?
| | Protein Kinase Inhibitors | 2 | 2014 | 971 | 0.130 |
Why?
| | Tight Junctions | 2 | 2015 | 81 | 0.130 |
Why?
| | Interleukin-13 | 1 | 2018 | 144 | 0.130 |
Why?
| | Alveolar Epithelial Cells | 1 | 2018 | 120 | 0.130 |
Why?
| | Cell Adhesion Molecules | 1 | 2018 | 178 | 0.130 |
Why?
| | Animals | 10 | 2016 | 37948 | 0.120 |
Why?
| | Quinazolines | 2 | 2014 | 266 | 0.120 |
Why?
| | Receptor, ErbB-3 | 1 | 2016 | 48 | 0.120 |
Why?
| | Forced Expiratory Volume | 1 | 2017 | 448 | 0.120 |
Why?
| | Cluster Analysis | 1 | 2017 | 516 | 0.120 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 387 | 0.110 |
Why?
| | Coronavirus Infections | 1 | 2020 | 381 | 0.110 |
Why?
| | Epidermal Growth Factor | 2 | 2012 | 161 | 0.110 |
Why?
| | Critical Care | 1 | 2020 | 695 | 0.110 |
Why?
| | Humans | 20 | 2020 | 144667 | 0.110 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 2 | 2014 | 1186 | 0.100 |
Why?
| | Sleep | 1 | 2020 | 890 | 0.100 |
Why?
| | Pulmonary Alveoli | 2 | 2015 | 383 | 0.100 |
Why?
| | Enzyme Activation | 1 | 2014 | 762 | 0.100 |
Why?
| | RNA Interference | 1 | 2014 | 473 | 0.090 |
Why?
| | Radiography, Thoracic | 1 | 2013 | 172 | 0.090 |
Why?
| | History, 20th Century | 1 | 2013 | 327 | 0.090 |
Why?
| | Mice, Inbred C57BL | 2 | 2016 | 5967 | 0.090 |
Why?
| | Pandemics | 1 | 2020 | 1700 | 0.090 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2012 | 161 | 0.080 |
Why?
| | Blood-Air Barrier | 1 | 2011 | 11 | 0.080 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2010 | 77 | 0.080 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 919 | 0.080 |
Why?
| | Myosin Light Chains | 2 | 2010 | 26 | 0.080 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2009 | 751 | 0.070 |
Why?
| | Endothelial Protein C Receptor | 1 | 2009 | 6 | 0.070 |
Why?
| | Stress, Mechanical | 2 | 2009 | 494 | 0.070 |
Why?
| | Pulmonary Edema | 1 | 2009 | 105 | 0.070 |
Why?
| | Interleukin-1beta | 1 | 2011 | 390 | 0.070 |
Why?
| | Mice, Mutant Strains | 1 | 2009 | 300 | 0.070 |
Why?
| | Thromboplastin | 1 | 2008 | 64 | 0.070 |
Why?
| | rho-Associated Kinases | 1 | 2009 | 82 | 0.070 |
Why?
| | Thrombin | 2 | 2010 | 167 | 0.070 |
Why?
| | Capillaries | 1 | 2009 | 118 | 0.070 |
Why?
| | Gene Expression | 2 | 2010 | 1476 | 0.070 |
Why?
| | Cells, Cultured | 3 | 2018 | 4110 | 0.060 |
Why?
| | Transfection | 2 | 2010 | 924 | 0.060 |
Why?
| | Pulmonary Circulation | 1 | 2009 | 429 | 0.060 |
Why?
| | Protein Binding | 2 | 2019 | 2243 | 0.060 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2012 | 1742 | 0.060 |
Why?
| | Mice | 4 | 2011 | 18261 | 0.060 |
Why?
| | Middle Aged | 4 | 2020 | 35971 | 0.060 |
Why?
| | rac GTP-Binding Proteins | 1 | 2005 | 35 | 0.060 |
Why?
| | Threonine | 1 | 2005 | 44 | 0.060 |
Why?
| | Genes, Dominant | 1 | 2005 | 100 | 0.050 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2005 | 56 | 0.050 |
Why?
| | Polymorphism, Genetic | 2 | 2005 | 613 | 0.050 |
Why?
| | Immunoprecipitation | 1 | 2005 | 147 | 0.050 |
Why?
| | Case-Control Studies | 1 | 2012 | 3603 | 0.050 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 1961 | 0.050 |
Why?
| | Serine | 1 | 2005 | 142 | 0.050 |
Why?
| | Endothelial Cells | 1 | 2010 | 864 | 0.050 |
Why?
| | Cytoskeleton | 1 | 2005 | 197 | 0.050 |
Why?
| | Female | 5 | 2020 | 78304 | 0.050 |
Why?
| | Male | 5 | 2020 | 72431 | 0.050 |
Why?
| | Microscopy, Fluorescence | 1 | 2005 | 407 | 0.050 |
Why?
| | Actins | 1 | 2005 | 421 | 0.050 |
Why?
| | Sepsis | 2 | 2005 | 643 | 0.040 |
Why?
| | Biomarkers | 1 | 2012 | 4261 | 0.040 |
Why?
| | Inflammation | 1 | 2012 | 2870 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2005 | 2019 | 0.040 |
Why?
| | Disease Models, Animal | 1 | 2011 | 4539 | 0.040 |
Why?
| | Etoposide | 1 | 2020 | 168 | 0.040 |
Why?
| | Treatment Failure | 1 | 2020 | 365 | 0.040 |
Why?
| | Receptors, Interleukin-6 | 1 | 2019 | 47 | 0.040 |
Why?
| | Advisory Committees | 1 | 2020 | 228 | 0.040 |
Why?
| | Genetic Predisposition to Disease | 2 | 2005 | 2350 | 0.040 |
Why?
| | Cell Line, Tumor | 2 | 2019 | 3523 | 0.040 |
Why?
| | Sirolimus | 1 | 2020 | 280 | 0.030 |
Why?
| | Consensus | 1 | 2020 | 475 | 0.030 |
Why?
| | Cisplatin | 1 | 2020 | 339 | 0.030 |
Why?
| | Aged | 2 | 2020 | 25955 | 0.030 |
Why?
| | Critical Illness | 1 | 2004 | 888 | 0.030 |
Why?
| | Betacoronavirus | 1 | 2020 | 286 | 0.030 |
Why?
| | Primary Cell Culture | 1 | 2018 | 172 | 0.030 |
Why?
| | Adult | 3 | 2020 | 40489 | 0.030 |
Why?
| | Models, Biological | 1 | 2005 | 1811 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2020 | 925 | 0.030 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2020 | 452 | 0.030 |
Why?
| | Europe | 1 | 2017 | 419 | 0.030 |
Why?
| | Societies, Medical | 1 | 2020 | 890 | 0.030 |
Why?
| | Computational Biology | 2 | 2014 | 681 | 0.030 |
Why?
| | Up-Regulation | 1 | 2018 | 848 | 0.030 |
Why?
| | United States | 3 | 2020 | 16018 | 0.030 |
Why?
| | Time Factors | 1 | 2005 | 7140 | 0.030 |
Why?
| | Biological Transport | 1 | 2015 | 418 | 0.020 |
Why?
| | Aniline Compounds | 1 | 2014 | 121 | 0.020 |
Why?
| | Nitriles | 1 | 2014 | 205 | 0.020 |
Why?
| | Quinolines | 1 | 2014 | 192 | 0.020 |
Why?
| | Protein Kinases | 1 | 2014 | 314 | 0.020 |
Why?
| | Tomography, Spiral Computed | 1 | 2011 | 30 | 0.020 |
Why?
| | Mutation | 2 | 2014 | 4081 | 0.020 |
Why?
| | Sequence Analysis, RNA | 1 | 2014 | 442 | 0.020 |
Why?
| | Biopsy, Needle | 1 | 2011 | 184 | 0.020 |
Why?
| | Occludin | 1 | 2010 | 11 | 0.020 |
Why?
| | Bronchoscopy | 1 | 2011 | 227 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2017 | 3414 | 0.020 |
Why?
| | Phenotype | 1 | 2017 | 3147 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2018 | 2591 | 0.020 |
Why?
| | Hydrogen Peroxide | 1 | 2010 | 334 | 0.020 |
Why?
| | Body Mass Index | 1 | 2017 | 2419 | 0.020 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2014 | 881 | 0.020 |
Why?
| | Global Health | 1 | 2011 | 401 | 0.020 |
Why?
| | Occupational Exposure | 1 | 2011 | 355 | 0.020 |
Why?
| | Gene Expression Profiling | 2 | 2005 | 1766 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2011 | 1465 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2010 | 1363 | 0.020 |
Why?
| | Comorbidity | 1 | 2011 | 1652 | 0.020 |
Why?
| | Nicotinamide Phosphoribosyltransferase | 1 | 2005 | 8 | 0.010 |
Why?
| | MEDLINE | 1 | 2004 | 20 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2010 | 1159 | 0.010 |
Why?
| | Dogs | 1 | 2005 | 438 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2010 | 3109 | 0.010 |
Why?
| | Databases, Genetic | 1 | 2004 | 247 | 0.010 |
Why?
| | Genetics, Population | 1 | 2004 | 215 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2010 | 2815 | 0.010 |
Why?
| | Genotype | 1 | 2005 | 1847 | 0.010 |
Why?
| | Adolescent | 1 | 2018 | 22409 | 0.010 |
Why?
| | Cytokines | 1 | 2005 | 2045 | 0.010 |
Why?
| | Rats | 1 | 2005 | 5570 | 0.010 |
Why?
|
|
Finigan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|